BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 19117750)

  • 1. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
    Bray F; Parkin DM
    Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
    Parkin DM; Bray F
    Eur J Cancer; 2009 Mar; 45(5):756-64. PubMed ID: 19128954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Danish Cancer Registry--history, content, quality and use.
    Storm HH; Michelsen EV; Clemmensen IH; Pihl J
    Dan Med Bull; 1997 Nov; 44(5):535-9. PubMed ID: 9408738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparability of colorectal cancer survival data in three European population-based registries.
    Monnet E; Faivre J; Raymond L; Garau I
    Eur J Cancer Prev; 1998 Apr; 7(2):127-34. PubMed ID: 9818774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data quality at population-based cancer registries in Colombia.
    Cendales R; Pardo C; Uribe C; López G; Yepez MC; Bravo LE
    Biomedica; 2012; 32(4):536-44. PubMed ID: 23715229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project.
    Steliarova-Foucher E; Kaatsch P; Lacour B; Pompe-Kirn V; Eser S; Miranda A; Danzon A; Ratiu A; Parkin DM
    Eur J Cancer; 2006 Sep; 42(13):1915-51. PubMed ID: 16919762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Incidence in Five Continents. Comparability and quality of data.
    Parkin DM; Muir CS
    IARC Sci Publ; 1992; (120):45-173. PubMed ID: 1284606
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal replacement therapy registries--time for a structured data quality evaluation programme.
    Couchoud C; Lassalle M; Cornet R; Jager KJ
    Nephrol Dial Transplant; 2013 Sep; 28(9):2215-20. PubMed ID: 23386707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer registration in Denmark and the study of multiple primary cancers, 1943-80.
    Jensen OM; Storm HH; Jensen HS
    Natl Cancer Inst Monogr; 1985 Dec; 68():245-51. PubMed ID: 4088300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparability issues of survival data.
    Ferretti S; Federico M; Contiero P; Stracci F
    Epidemiol Prev; 2001; 25(3 Suppl):37-41. PubMed ID: 11695202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Danish Cancer Registry.
    Gjerstorff ML
    Scand J Public Health; 2011 Jul; 39(7 Suppl):42-5. PubMed ID: 21775350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality evaluation of national cancer registry system in Iran: study protocol.
    Modirian M; Rahimzadeh S; Cheraghi Z; Khosravi A; Salimzadeh H; Kompani F; Rezaei N; Qorbani M; Delavari A; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):193-7. PubMed ID: 24621363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
    Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensuring quality in studies linking cancer registries and biobanks.
    Langseth H; Luostarinen T; Bray F; Dillner J
    Acta Oncol; 2010 Apr; 49(3):368-77. PubMed ID: 20059313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Global activity of cancer registries and cancer control and cancer incidence statistics in Korea].
    Shin HR
    J Prev Med Public Health; 2008 Mar; 41(2):84-91. PubMed ID: 18385548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A validation of estimating the national cancer incidence in Korea using the databases of 7 population-based regional cancer registries except Seoul].
    Community of Population-based Regional Cancer Registries in Korea
    J Prev Med Public Health; 2009 Mar; 42(2):130-4. PubMed ID: 19349743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cancer registry in cancer control--a review.
    Muir CS
    Arch Geschwulstforsch; 1984; 54(6):491-7. PubMed ID: 6395824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using cancer registry data for survival studies: the example of the Ontario Cancer Registry.
    Hall S; Schulze K; Groome P; Mackillop W; Holowaty E
    J Clin Epidemiol; 2006 Jan; 59(1):67-76. PubMed ID: 16360563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.